Breaking News: Yotta Acquisition Corporation Extends Combination Period and Boosts Trust Account Contribution for a Longer Combination Period!

Yotta Acquisition Corporation Announces Extension of Combination Period and Additional Contribution Yotta Investment LLC Makes Significant Deposit into Company’s Trust Account NEW YORK, Jan. 26, 2023 (GLOBE NEWSWIRE) — Yotta Acquisition Corporation (NASDAQ: YOTA, the “Company”), a special purpose acquisition company, announced today that Yotta Investment LLC, the Company’s initial public offering sponsor (“Sponsor”), has…

Read More

“Discover the Power of Mindfulness: A Guide to Finding Inner Peace and Clarity”

Robert Kaplan Discusses Fed’s Inflation Fight and Economy Outlook Introduction Robert Kaplan, Vice Chairman of Goldman Sachs and former Dallas Fed President, recently appeared on ‘Squawk Box’ to share his insights on the Federal Reserve’s current battle against inflation. During the interview, he discussed what to expect from the central bank’s upcoming two-day policy meeting,…

Read More

DoubleDown Interactive Secures Acquisition of iGaming Operator Suprnation through Share Purchase Agreement: A Strategic Move for Business Success

DoubleDown Interactive Enters into Share Purchase Agreement to Acquire i-Gaming Operator, SuprNation SEATTLE, Jan. 11, 2023 (GLOBE NEWSWIRE) — DoubleDown Interactive Co., Ltd. (NASDAQ: DDI) (“DoubleDown” or the “Company”), a leading gaming company, delivering unique player experiences across a variety of genres, today announced that the Company has entered into a Share Purchase Agreement (the…

Read More

Breaking News: Orion and Bayer Team Up Again to Bring Darolutamide to EU for Third Indication!

Orion Corporation Investor News 14 October 2024 at 11.00 EEST Orion’s collaboration partner Bayer submits application for third indication of darolutamide in the EU Orion’s collaboration partner Bayer has made a significant move in the field of prostate cancer treatment by submitting an application to the European Medicines Agency (EMA) for the oral androgen receptor…

Read More